Institutional Ownership
Scinai Immunotherapeutics Lt
CUSIP 09073Q303SPONSORED ADRSCNIQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
5.0%
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Nov 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 5.0% | 44.8K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Xtx Topco Ltd | 24.0K | $13.3K |
| 2 | Rhumbline Advisers | 1.9K | $1.0K |
| 3 | Ubs Group AG | 919 | $524 |
| 4 | Morgan Stanley | 58 | $33 |